Keshav R. Rao

Neurology

1000 Asylum Ave Ste 4304
Hartford, CT 06105

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine.

ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine.

Journal: Blood cancer journal

Published: February 08, 2021

Showing 1-1 of 1

Last Updated: 09/26/2026